Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jun 30:2022:3573963.
doi: 10.1155/2022/3573963. eCollection 2022.

The Significance of Exposure to Pregestational Type 2 Diabetes in Utero on Fetal Renal Size and Subcutaneous Fat Thickness

Christy L Pylypjuk  1   2 , Chelsea Day  1   2 , Yasmine ElSalakawy  1 , Gregory J Reid  1
Affiliations

The Significance of Exposure to Pregestational Type 2 Diabetes in Utero on Fetal Renal Size and Subcutaneous Fat Thickness

Christy L Pylypjuk et al. Int J Nephrol. .

Abstract

Objectives: To determine the relationship between exposure to pregestational type 2 diabetes (T2D) and renal size and subcutaneous fat thickness in fetuses during routine obstetrical ultrasound.

Methods: This was a case-control study (January 1, 2019 to December 31, 2019). Routine obstetrical ultrasounds performed between 18 and 22 weeks' gestation at a tertiary-care fetal assessment unit were reviewed. "Cases" comprised ultrasounds of fetuses exposed to pregestational T2D in utero. The control group was assembled from ultrasounds of healthy controls. Postprocessing measurements of fetal renal size and abdominal wall thickness from stored images were performed by two independent observers, and findings were compared between groups.

Results: There were 54 cases and 428 ultrasounds of healthy controls. The mean maternal age of cases was 32.1 years (SD 6.2) compared to 33.2 years (SD 5.3) for healthy controls, and the majority of ultrasounds were performed in multiparous patients (83%). At the 18 to 22 week ultrasound, there was a significant reduction in renal size amongst fetuses exposed to maternal T2D in utero compared to controls; among cases, the mean renal width was 8.0 mm (95% CI 7.8-8.1) compared to 11.4 mm (95% CI 10.6-12.7) in controls (p < 0.0001); the mean renal thickness among cases was 8.1 mm (95% CI 7.9-8.2) compared to 11.5 mm (95% CI 10.7-12.9) in controls (p=0.001). There was no obvious difference in estimated fetal weight between groups, yet fetuses exposed to maternal T2D had increased subcutaneous abdominal wall fat thickness at this early gestational age (p=0.008).

Conclusions: Fetal renal size in cases exposed to pregestational T2D is significantly smaller compared to controls, and subcutaneous abdominal wall fat is significantly thicker. Given emerging evidence about the developmental origins of disease, further study is needed to correlate the association between fetal renal size and fat distribution in the fetus and the long-term risk of chronic renal disease and diabetes in these offspring.

PubMed Disclaimer

Conflict of interest statement

The authors declare that there are no conflicts of interest regarding the publication of this paper.

Figures

Figure 1
Figure 1
Flow diagram of study subjects. amnio = genetic amniocentesis.
Figure 2
Figure 2
Fetal renal thickness and width (means with 95% confidence intervals) comparing cases and controls.
Figure 3
Figure 3
Fetal abdominal wall thickness (means with 95% confidence intervals) comparing cases and controls. AWT = abdominal wall thickness.
Figure 4
Figure 4
Estimated fetal weight (means with 95% confidence intervals) comparing cases and controls. EFW = estimated fetal weight.
See this image and copyright information in PMC

References

    1. Global Report on Diabetes . Geneva, Switzerland: World Health Organization; 2016.
    1. Cho N. H., Shaw J. E., Karuranga S., et al. IDF Diabetes Atlas: global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Research and Clinical Practice . 2018;138:271–281. doi: 10.1016/j.diabres.2018.02.023. - DOI - PubMed
    1. Mackin S. T., Nelson S. M., Kerssens J. J., et al. Diabetes and pregnancy: national trends over a 15 year period. Diabetologia . 2018;61(5):1081–1088. doi: 10.1007/s00125-017-4529-3. - DOI - PMC - PubMed
    1. Pylypjuk C., Sellers E., Wicklow B. Perinatal outcomes in a longitudinal birth cohort of First Nations mothers with pregestational type 2 diabetes and their offspring: the Next Generation Study. Canadian Journal of Diabetes . 2021;45(1):27–32. doi: 10.1016/j.jcjd.2020.05.001. - DOI - PubMed
    1. Feig D. S., Hwee J., Shah B. R, Booth G. L., Bierman A. S., Lipscombe L. L. Trends in incidence of diabetes in pregnancy and serious perinatal outcomes: a large, population-based study in Ontario, Canada, 1996–2010. Diabetes Care . 2014;37(6):1590–1596. doi: 10.2337/dc13-2717. - DOI - PubMed

LinkOut - more resources